Approved Vesting Of Oncology, Profertility Division Of Sarabhai Chemicals
13/01/2023 14:32
Jan 13 (Reuters) - Ambalal Sarabhai Enterprises Ltd
AMBL.BO :
* AMBALAL SARABHAI ENTERPRISES LTD - APPROVED DEMERGER,
VESTING OF
ONCOLOGY, PROFERTILITY DIVISION OF SARABHAI CHEMICALS INTO
ASENCE PHARMA
Source text for Eikon: ID:nBSE66hhDm
Further company coverage: AMBL.BO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ambalal Sarabhai Enterprises
See all newsBrief: Ambalal Sarabhai Enterprises Says Telerad Division Of Unit Signs Agreement With Bolin Technology
Brief: Ambalal Sarabhai Enterprises Says CFO Navinchandra Patel Resigns
Brief: Ambalal Sarabhai Enterprises Names Mohal K. Sarabhai As MD
Brief: Ambalal Sarabhai Enterprises Says Unit Asence Pharma Commences New Oncology And Synthetic API Plant At Ranoli, Vadodara
Brief: India's Ambalal Sarabhai Enterprises Dec-Qtr Consol Net Profit Falls